GB2142021B - 1 4-dihydropyridine derivatives their preparation and pharmaceutical compositions containing them - Google Patents

1 4-dihydropyridine derivatives their preparation and pharmaceutical compositions containing them

Info

Publication number
GB2142021B
GB2142021B GB08415523A GB8415523A GB2142021B GB 2142021 B GB2142021 B GB 2142021B GB 08415523 A GB08415523 A GB 08415523A GB 8415523 A GB8415523 A GB 8415523A GB 2142021 B GB2142021 B GB 2142021B
Authority
GB
United Kingdom
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
dihydropyridine derivatives
dihydropyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08415523A
Other languages
English (en)
Other versions
GB8415523D0 (en
GB2142021A (en
Inventor
Arnold Vogel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB8415523D0 publication Critical patent/GB8415523D0/en
Publication of GB2142021A publication Critical patent/GB2142021A/en
Application granted granted Critical
Publication of GB2142021B publication Critical patent/GB2142021B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB08415523A 1983-06-21 1984-06-18 1 4-dihydropyridine derivatives their preparation and pharmaceutical compositions containing them Expired GB2142021B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH339483 1983-06-21

Publications (3)

Publication Number Publication Date
GB8415523D0 GB8415523D0 (en) 1984-07-25
GB2142021A GB2142021A (en) 1985-01-09
GB2142021B true GB2142021B (en) 1987-07-15

Family

ID=4255028

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08415523A Expired GB2142021B (en) 1983-06-21 1984-06-18 1 4-dihydropyridine derivatives their preparation and pharmaceutical compositions containing them

Country Status (15)

Country Link
JP (1) JPS6013789A (fr)
AU (1) AU2956484A (fr)
BE (1) BE899937A (fr)
CH (1) CH663616A5 (fr)
DE (1) DE3421992A1 (fr)
DK (1) DK299784A (fr)
FR (1) FR2549058B1 (fr)
GB (1) GB2142021B (fr)
IL (1) IL72152A0 (fr)
IT (1) IT1199143B (fr)
LU (1) LU85423A1 (fr)
NL (1) NL8401932A (fr)
SE (1) SE8403268L (fr)
WO (1) WO1985000169A1 (fr)
ZA (1) ZA844725B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4755512A (en) * 1984-04-11 1988-07-05 Bristol-Myers Company Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters incorporating arylpiperazinylalkyl moities
NL8503262A (nl) * 1984-12-10 1986-07-01 Sandoz Ag 1,4-dihydropyridinederivaten, werkwijze voor het bereiden van deze derivaten en farmaceutische preparaten die ze bevatten.
EP0191724A3 (fr) * 1985-01-15 1986-12-03 Sandoz Ag 1,4-Dihydropyridines, leur procédé de préparation et les compositions pharmaceutiques les contenant
US4659717A (en) * 1985-08-21 1987-04-21 Eli Lilly And Company Dihydropyridines useful in the treatment of angina and stroke
EP0222702A3 (fr) * 1985-11-06 1988-01-07 Ciba-Geigy Ag Dérivés carbonyliques basiques
US4868181A (en) * 1986-08-04 1989-09-19 E. I. Du Pont De Nemours And Company 1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity
WO1988007531A1 (fr) * 1987-03-27 1988-10-06 Byk Gulden Lomberg Chemische Fabrik Gmbh Nouveaux composes optiquement actifs
US4994461A (en) * 1987-03-27 1991-02-19 Byk Gulden Lomberg Chemische Fabrik Gmbh 1,4-dihydropyridine enantiomers
JPH03500647A (ja) * 1987-10-27 1991-02-14 ビイク　グルデン　ロンベルク　ヒエーミツシエ　フアブリーク　ゲゼルシヤフト　ミツト　ベシユレンクテル　ハフツング 新規ピロリジン
JPH10205466A (ja) * 1997-01-23 1998-08-04 Mitsubishi Heavy Ind Ltd スクロール型流体機械

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2949464A1 (de) * 1978-12-18 1980-06-26 Sandoz Ag Benzoxadiazole und benzothiadiazole, ihre herstellung und verwendung
DE3022030A1 (de) * 1980-06-12 1981-12-17 Bayer Ag, 5090 Leverkusen 4-thiazol- bzw. 4-imidazol-substituierte, 1,4-dihydropyridine, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
JPS57175165A (en) * 1981-04-21 1982-10-28 Tokyo Tanabe Co Ltd Novel 1,4-dihydropyridine-3,5-dicarboxylic diester derivative and its salt
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
EP0094159B1 (fr) * 1982-05-10 1990-03-14 Takeda Chemical Industries, Ltd. Dérivés de la dihydropyridine, leur préparation et leur application

Also Published As

Publication number Publication date
DK299784A (da) 1984-12-22
SE8403268D0 (sv) 1984-06-19
SE8403268L (sv) 1984-12-22
AU2956484A (en) 1985-01-03
IL72152A0 (en) 1984-10-31
DK299784D0 (da) 1984-06-19
BE899937A (fr) 1984-12-18
WO1985000169A1 (fr) 1985-01-17
ZA844725B (en) 1986-02-26
GB8415523D0 (en) 1984-07-25
CH663616A5 (de) 1987-12-31
FR2549058B1 (fr) 1988-02-19
GB2142021A (en) 1985-01-09
NL8401932A (nl) 1985-01-16
FR2549058A1 (fr) 1985-01-18
LU85423A1 (fr) 1985-03-26
DE3421992A1 (de) 1985-01-03
IT1199143B (it) 1988-12-30
JPS6013789A (ja) 1985-01-24
IT8448415A0 (it) 1984-06-19

Similar Documents

Publication Publication Date Title
IL73706A0 (en) 2,2'-iminobisethanol derivatives,their preparation and pharmaceutical compositions containing them
IL72028A0 (en) Aminomethyl-oxooxazolidinylbenzene derivatives and pharmaceutical compositions containing them
IL76405A0 (en) 1,3-diacyl-2-oxyindole derivatives,their preparation and pharmaceutical compositions containing them
GB2091262B (en) 3-aminoprpoxyaryl derivatives their preparation and pharmaceutical compositions containing them
IL74865A (en) 4'-amino-9a-aza-9a-homoerythromycin derivatives and pharmaceutical compositions containing them
IL71187A0 (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions containing them
IL73332A (en) 5-amino-6-phenyl-2,3-dihydro-3-imino-1,2,4-triazine derivatives,their preparation and pharmaceutical compositions containing them
NZ209064A (en) N 6 -diarylalkyl-adenosine derivatives and pharmaceutical compositions
IL82205A0 (en) Substituted alkanesulfonamidophenyl derivatives and pharmaceutical compositions containing them
IL75943A (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
IL83413A0 (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
IL72562A (en) 6,7-dimethoxy-4-piperidino-quinazoline derivatives and pharmaceutical compositions containing them
GB2142021B (en) 1 4-dihydropyridine derivatives their preparation and pharmaceutical compositions containing them
IL75411A0 (en) Dihydropyridines and pharmaceutical compositions containing them
IL75242A0 (en) Pharmaceutical compositions containing dihydropyridines and their preparation
ZA86301B (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
GB2121037B (en) 2(1h)-pyridinone derivatives their preparation and pharmaceutical compositions containing them
GB2167414B (en) Flavolignan derivatives and pharmaceutical compositions containing them
IL75427A0 (en) Dihydropyridines and pharmaceutical compositions containing them
IL73509A (en) 1,4-dihydro-3-carbamoyl pyridines,their preparation and pharmaceutical compositions comprising them
DE3473444D1 (en) Acylindole derivatives and pharmaceutical compositions containing them
NZ208694A (en) Rooperol derivatives and pharmaceutical compositions
IL80540A0 (en) Dihydropyridine derivatives and pharmaceutical compositions containing them
IL73278A0 (en) Pharmaceutical compositions containing 1,2-dithiolan derivatives,certain such derivatives and their preparation
IL74071A0 (en) Dihydropyridine derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee